Goulart Stollmaier, J.; Thomson, J.; Endoma-Arias, M.A.; Simionescu, R.; Vernaza, A.; Mesa-Diaz, N.; Smith, M.; Du, L.; Kornienko, A.; Hudlicky, T.
Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine. Molecules 2022, 27, 4141.
https://doi.org/10.3390/molecules27134141
AMA Style
Goulart Stollmaier J, Thomson J, Endoma-Arias MA, Simionescu R, Vernaza A, Mesa-Diaz N, Smith M, Du L, Kornienko A, Hudlicky T.
Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine. Molecules. 2022; 27(13):4141.
https://doi.org/10.3390/molecules27134141
Chicago/Turabian Style
Goulart Stollmaier, Juana, Jared Thomson, Mary Ann Endoma-Arias, Razvan Simionescu, Alexandra Vernaza, Nakya Mesa-Diaz, Mitchell Smith, Liqin Du, Alexander Kornienko, and Tomas Hudlicky.
2022. "Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine" Molecules 27, no. 13: 4141.
https://doi.org/10.3390/molecules27134141
APA Style
Goulart Stollmaier, J., Thomson, J., Endoma-Arias, M. A., Simionescu, R., Vernaza, A., Mesa-Diaz, N., Smith, M., Du, L., Kornienko, A., & Hudlicky, T.
(2022). Conversion of Natural Narciclasine to Its C-1 and C-6 Derivatives and Their Antitumor Activity Evaluation: Some Unusual Chemistry of Narciclasine. Molecules, 27(13), 4141.
https://doi.org/10.3390/molecules27134141